Last reviewed · How we verify
NCT05334121: HIPOX-β
Safety Analysis of Chronic Intake of a β-alanine Supplement
NA trial testing Beta-alanine in Product Safety in 20 participants. Completed in 31 May 2022.
25 April 2022
Quick facts
| Lead sponsor | Universidad Católica San Antonio de Murcia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | other |
| Enrollment | 20 |
| Start date | 21 March 2022 |
| Primary completion | 25 April 2022 |
| Estimated completion | 31 May 2022 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Beta-alanine — full drug profile →
- Control product consumption
Conditions studied
- Product Safety — all drugs for Product Safety →
Sponsor
Universidad Católica San Antonio de Murcia
Who can join
Adults 18 to 40, male only, with Product Safety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Single-center, double-blind, placebo-controlled clinical trial with two arms (product and placebo) to analyze the safety of beta-alanine consumption in active people.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effect of a sustained-release formulation of β-alanine on laboratory parameters and paresthesia in recreational trained men: a randomized double-blind placebo-controlled study.
Maestre-Hernández AB, Pérez-Piñero S, López-Román FJ, Andreu-Caravaca L, et al · · 2023 · cited 1× · PMID 37766731 · DOI 10.3389/fnut.2023.1213105
Verify or expand the search:
- PubMed search for NCT05334121
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Beta-alanine
Trials testing the same drug.
- NCT05772988 — Beta-alanine Supplementation and CrossFit Performance · NA · completed
- NCT05329610 — β-alanine Supplementation in Adults With Overweight/Obesity · NA · completed
- NCT03708185 — Beta-alanine Supplementation and High-intensity Interval Training · NA · completed
- NCT03655041 — 24-Wk β-Alanine Ingestion on Muscle Taurine and Clinical Blood Parameters in Healthy Males · NA · completed
Other Universidad Católica San Antonio de Murcia trials
Trials by the same sponsor.
- NCT07397910 — Clinical Trial on a Natural Compound to Improve Chronic Inflammation After SARS-CoV-2 Infection · NA · not yet recruiting
- NCT07519980 — Xanthigen and Its Impact on Weight and Metabolic Health · NA · recruiting
- NCT07391189 — Healthy Effects of Adapted Aikido in People With Grip Disfunction · NA · recruiting
- NCT07379931 — Evaluating a Liquid Extract of Carob to Improve Blood Sugar in People With Prediabetes · NA · not yet recruiting
- NCT07488000 — Plyometric Exercises During the Winter Pre-season in Sprinters · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05334121 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Católica San Antonio de Murcia
- Last refreshed: 26 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05334121.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing